Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Outcome Surveillance Using AlloSure and AlloMap Guided Immunomodulation in Cardiac Transplant

NCT05459181 is registered in ClinicalTrials.gov with CareDx as lead sponsor.

NCT NCT05459181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05459181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Outcome Surveillance Using AlloSure and AlloMap Guided Immunomodulation in Cardiac Transplant
Lead sponsor
CareDx
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2025
Completion date
September 30, 2026
Enrollment
930 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allograft, heart transplant, immunosuppression